Psychiatric Institute of Washington participates in clinical trials for new medications to treat schizophrenia and bipolar disorders. Participants meeting the required criteria of the clinical research programs are admitted at no cost.
A medical and psychiatric evaluation is performed on all participants. Patients must be 18 years of age or older and have a diagnosis of chronic or subchronic schizophrenia, schizoaffective or bi-polar disorder and must meet study specific requirements. Both inpatient and outpatient studies are available.